“IN SILICO SCREENING OF EFAVIRENZ AND EFAVIRENZ NICOTINAMIDE COCRYSTAL FOR ITS ACTIVITY AGAINST HIV AND SARS COV-2”, NUJPS, vol. 10, no. 1, pp. 71–86, Aug. 2024, doi: 10.5281/.